ROIVANT SCIENCES LTD. (ROIV) ROI
- 2024-06-30: ROI 82.24%.
- 2024-03-31: ROI 67.83%.
- 2023-12-31: ROI 68.31%.
- 2023-09-30: ROI -70.79%.
Complete source-backed roi history.
- Available history
- 2021-03-31 to 2024-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2024-06-30 | 82.24% |
| 2024-03-31 | 67.83% |
| 2023-12-31 | 68.31% |
| 2023-09-30 | -70.79% |
| 2023-06-30 | -72.31% |
| 2023-03-31 | -64.11% |
| 2022-12-31 | -91.02% |
| 2022-09-30 | -74.92% |
| 2022-06-30 | -60.79% |
| 2022-03-31 | -45.27% |
| 2021-12-31 | -52.41% |
| 2021-09-30 | -47.42% |
| 2021-06-30 | -46.51% |
| 2021-03-31 | -41.12% |
Annual ROI
| Date | ROI |
|---|---|
| 2024-03-31 | 67.83% |
| 2023-03-31 | -64.11% |
| 2022-03-31 | -45.27% |
| 2021-03-31 | -41.12% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |